CLINICAL TRIALS PROFILE FOR NUMORPHAN
✉ Email this page to a colleague
All Clinical Trials for NUMORPHAN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00904280 ↗ | Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy | Completed | Endo Pharmaceuticals | Phase 3 | 2001-03-01 | The purpose of this study is to evaluate the long-term safety and tolerability of oxymorphone ER as an analgesic in cancer and lower back pain subjects having chronic moderate to severe pain. |
| NCT00904449 ↗ | Open Label Assessment of Long-Term Safety and Utility | Completed | Endo Pharmaceuticals | Phase 3 | 2001-04-01 | The purpose of this study is to monitor the long-term analgesic effectiveness, safety, and utility of oxymorphone ER for the relief of moderate to severe pain due to cancer. |
| NCT03579446 ↗ | Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer | Active, not recruiting | National Cancer Institute (NCI) | Early Phase 1 | 2018-11-29 | This early phase I trial studies how well levorphanol works as a second line opioid in reducing pain in patients with cancer that may have spread to other places in the body. Levorphanol may work better in controlling cancer pain. |
| NCT03579446 ↗ | Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer | Active, not recruiting | M.D. Anderson Cancer Center | Early Phase 1 | 2018-11-29 | This early phase I trial studies how well levorphanol works as a second line opioid in reducing pain in patients with cancer that may have spread to other places in the body. Levorphanol may work better in controlling cancer pain. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NUMORPHAN
Condition Name
Clinical Trial Locations for NUMORPHAN
Trials by Country
Clinical Trial Progress for NUMORPHAN
Clinical Trial Phase
Clinical Trial Sponsors for NUMORPHAN
Sponsor Name
